• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

白塞病的眼部表现及其并发症与视力和治疗的相关性

Correlation between Ocular Manifestations and Their Complications as Opposed to Visual Acuity and Treatment in Behcet's Disease.

作者信息

Paovic Jelena, Paovic Predrag, Sredovic Vojislav

机构信息

Department of Ophthalmology, University Clinical Center, Pasterova 2, 11000 Belgrade, Serbia.

出版信息

Autoimmune Dis. 2013;2013:842673. doi: 10.1155/2013/842673. Epub 2013 Aug 29.

DOI:10.1155/2013/842673
PMID:24073331
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3773399/
Abstract

The aim of this study was to analyze ocular manifestations, their complications, and treatment in a sample of 40 patients with confirmed Behcet's disease. Results. Serofibrinous iridocyclitis was the most common form of uveitis (60%). Retinal periphlebitis manifested in 92.5% of cases, and periphlebitis in conjunction with periarteritis was diagnosed in 72.5% of cases. Macular edema was the most frequent complication on the posterior segment (60%) and it correlated with periphlebitis (P = 0.45) and periphlebitis associated with periarteritis (P = 0.51). Cyclosporine A and corticosteroids were used in the majority of cases (67%). Following six months of therapy, a significant improvement of visual acuity occurred in patients with initial visual acuity >0.5 on both eyes. Level of visual acuity before and after treatment had a strong significant correlation coefficient with various ocular complications. Previously proven significant increase of visual acuity in patients with macular edema depicts effectiveness of treatment in these types of ocular manifestations of Behcet's disease. Conclusions. Significant improvement of visual acuity occurred in patients with initial visual acuity >0.5 on both eyes. The highest increase in visual acuity was achieved by laser photocoagulation in combination with triamcinolone acetonide P = 0.038 < 0.050.

摘要

本研究旨在分析40例确诊为白塞病患者的眼部表现、并发症及治疗情况。结果。浆液纤维蛋白性虹膜睫状体炎是葡萄膜炎最常见的形式(60%)。视网膜静脉周围炎在92.5%的病例中出现,72.5%的病例诊断为静脉周围炎合并动脉周围炎。黄斑水肿是后段最常见的并发症(60%),且与静脉周围炎(P = 0.45)及静脉周围炎合并动脉周围炎(P = 0.51)相关。大多数病例(67%)使用了环孢素A和皮质类固醇。治疗六个月后,初始双眼视力>0.5的患者视力有显著改善。治疗前后的视力水平与各种眼部并发症有很强的显著相关系数。先前已证实黄斑水肿患者视力显著提高,表明在白塞病的这些眼部表现类型中治疗有效。结论。初始双眼视力>0.5的患者视力有显著改善。激光光凝联合曲安奈德使视力提高最为显著(P = 0.038 < 0.050)。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/779b/3773399/24a49a5509d7/AD2013-842673.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/779b/3773399/3f4f1643f66c/AD2013-842673.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/779b/3773399/504e380465f8/AD2013-842673.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/779b/3773399/02ddba661efa/AD2013-842673.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/779b/3773399/8354cbb57454/AD2013-842673.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/779b/3773399/24a49a5509d7/AD2013-842673.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/779b/3773399/3f4f1643f66c/AD2013-842673.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/779b/3773399/504e380465f8/AD2013-842673.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/779b/3773399/02ddba661efa/AD2013-842673.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/779b/3773399/8354cbb57454/AD2013-842673.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/779b/3773399/24a49a5509d7/AD2013-842673.005.jpg

相似文献

1
Correlation between Ocular Manifestations and Their Complications as Opposed to Visual Acuity and Treatment in Behcet's Disease.白塞病的眼部表现及其并发症与视力和治疗的相关性
Autoimmune Dis. 2013;2013:842673. doi: 10.1155/2013/842673. Epub 2013 Aug 29.
2
Behcet's disease: systemic and ocular manifestations.贝赫切特病:全身表现和眼部表现。
Biomed Res Int. 2013;2013:247345. doi: 10.1155/2013/247345. Epub 2013 Oct 3.
3
Clinical Manifestations, Complications and Treatment of Ocular Sarcoidosis: Correlation between Visual Efficiency and Macular Edema as Seen on Optical Coherence Tomography.眼部结节病的临床表现、并发症及治疗:光学相干断层扫描显示的视觉效率与黄斑水肿之间的相关性
Semin Ophthalmol. 2016 Sep 14:1-8. doi: 10.1080/08820538.2016.1206576.
4
[Clinical features of patients with Behcet's uveitis].[白塞氏葡萄膜炎患者的临床特征]
Zhonghua Yan Ke Za Zhi. 2020 Mar 11;56(3):217-223. doi: 10.3760/cma.j.issn.0412-4081.2020.03.010.
5
Ocular Manifestations in Late Onset Behçet's Disease.迟发性白塞病的眼部表现
Curr Aging Sci. 2021;14(1):56-61. doi: 10.2174/1874609813666200128110820.
6
[Uveitic glaucoma in Behçet's disease: When everything gets complicated].[白塞病中的葡萄膜炎性青光眼:当一切都变得复杂时]
J Fr Ophtalmol. 2020 Sep;43(7):635-641. doi: 10.1016/j.jfo.2019.12.005. Epub 2020 Jul 1.
7
Adalimumab in Treatment of Uveitis in Pediatric Behcet's Disease-a Case Report.阿达木单抗治疗小儿白塞病性葡萄膜炎——一例报告
Mater Sociomed. 2021 Mar;33(1):78-81. doi: 10.5455/msm.2021.33.78-81.
8
Pattern and causes of visual loss in Behçet's uveitis: short-term and long-term outcomes.白塞氏葡萄膜炎视力丧失的模式及原因:短期和长期预后
Graefes Arch Clin Exp Ophthalmol. 2017 Jul;255(7):1423-1432. doi: 10.1007/s00417-017-3667-0. Epub 2017 Apr 10.
9
Pattern of uveitis in Behçet's disease in a referral center in Tunisia, North Africa.北非突尼斯一家转诊中心白塞病患者的葡萄膜炎模式
Int Ophthalmol. 2009 Jun;29(3):135-41. doi: 10.1007/s10792-008-9203-9. Epub 2008 Mar 26.
10
Intravitreal triamcinolone acetonide in the management of cystoid macular edema in Behçet's disease.玻璃体内注射曲安奈德治疗白塞病性黄斑囊样水肿
Graefes Arch Clin Exp Ophthalmol. 2007 Mar;245(3):451-6. doi: 10.1007/s00417-006-0514-0. Epub 2007 Jan 17.

引用本文的文献

1
From Retinal Vasculitis to Stroke, from Systemic Findings to Diagnosis, the Necessity of Multidisciplinary Management in Behçet's Disease: A Case Report.从视网膜血管炎到中风,从全身表现到诊断,白塞病多学科管理的必要性:一例病例报告
Case Rep Ophthalmol. 2025 Apr 4;16(1):317-322. doi: 10.1159/000545635. eCollection 2025 Jan-Dec.
2
Optimizing Behçet Uveitis Management: A Review of Personalized Immunosuppressive Strategies.优化贝赫切特葡萄膜炎的管理:个性化免疫抑制策略的综述。
Med Sci Monit. 2024 May 7;30:e943240. doi: 10.12659/MSM.943240.
3
Characteristics of Macular Edema in Behcet Disease after Intravitreal Bevacizumab Injection.

本文引用的文献

1
[Behcet's disease--ophthalmological and general aspects: Part 2: Therapy].[白塞病——眼科及全身情况:第二部分:治疗]
Ophthalmologe. 2013 Mar;110(3):273-84. doi: 10.1007/s00347-012-2780-z.
2
The International Criteria for Behçet's Disease (ICBD): a collaborative study of 27 countries on the sensitivity and specificity of the new criteria.国际白塞病诊断标准(ICBD):27 个国家对新标准敏感性和特异性的合作研究。
J Eur Acad Dermatol Venereol. 2014 Mar;28(3):338-47. doi: 10.1111/jdv.12107. Epub 2013 Feb 26.
3
Health- and vision-related quality of life in patients receiving infliximab therapy for Behcet uveitis.
玻璃体腔注射贝伐单抗后白塞病黄斑水肿的特征
J Ophthalmic Vis Res. 2017 Jan-Mar;12(1):44-52. doi: 10.4103/jovr.jovr_254_15.
接受英夫利昔单抗治疗的 Behcet 葡萄膜炎患者的健康和视力相关生活质量。
Br J Ophthalmol. 2013 Mar;97(3):338-42. doi: 10.1136/bjophthalmol-2012-302515. Epub 2013 Jan 12.
4
[Behçet's disease - ophthalmological and general aspects part I : etiology, pathogenesis and diagnostics].[白塞病——眼科及总体情况 第一部分:病因、发病机制与诊断]
Ophthalmologe. 2012 Nov;109(11):1129-41; quiz 1142-3. doi: 10.1007/s00347-012-2698-5.
5
Switching of anti-TNF-α agents in Behçet's disease.切换治疗白塞病的抗 TNF-α 药物。
Clin Exp Rheumatol. 2012 May-Jun;30(3 Suppl 72):S62-8. Epub 2012 Sep 27.
6
Behçet's syndrome: a critical digest of the recent literature.白塞综合征:近期文献的批判性综述。
Clin Exp Rheumatol. 2012 May-Jun;30(3 Suppl 72):S80-9. Epub 2012 Sep 25.
7
The 2009 prospective multi-center epidemiologic survey of uveitis in Japan.2009 年日本前瞻性多中心葡萄膜炎流行病学调查。
Jpn J Ophthalmol. 2012 Sep;56(5):432-5. doi: 10.1007/s10384-012-0158-z. Epub 2012 Jul 3.
8
[Treatment of Behçet's disease yesterday and today].[白塞病的过去与现在的治疗]
Ophthalmologe. 2012 Jun;109(6):568-74. doi: 10.1007/s00347-011-2504-9.
9
[Typical and atypical ocular manifestations of Behçet's disease].[白塞病的典型和非典型眼部表现]
Ophthalmologe. 2012 Jun;109(6):558-62. doi: 10.1007/s00347-012-2587-y.
10
Inhibition of Th17 differentiation by anti-TNF-alpha therapy in uveitis patients with Behçet's disease.抗 TNF-α 治疗对 Behcet 病葡萄膜炎患者 Th17 分化的抑制作用。
Arthritis Res Ther. 2012 May 1;14(3):R99. doi: 10.1186/ar3824.